236 related articles for article (PubMed ID: 8356929)
1. Proteases--structures, mechanism and inhibitors.
Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design.
Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T
J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proteolysis and other posttranslational modifications with substrate-targeted inhibitors.
Kodadek T
Biopolymers; 2002; 66(2):134-40. PubMed ID: 12325163
[TBL] [Abstract][Full Text] [Related]
4. Aspartic proteases involved in Alzheimer's disease.
Schmidt B
Chembiochem; 2003 May; 4(5):366-78. PubMed ID: 12740808
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics of proteases in the MEROPS database.
Barrett AJ
Curr Opin Drug Discov Devel; 2004 May; 7(3):334-41. PubMed ID: 15216937
[TBL] [Abstract][Full Text] [Related]
6. Effect of protease inhibitors on exflagellation in Plasmodium falciparum.
Rupp I; Bosse R; Schirmeister T; Pradel G
Mol Biochem Parasitol; 2008 Apr; 158(2):208-12. PubMed ID: 18243365
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic inhibitors targeting serine and aspartic acid proteases].
Reboud-Ravaux MC; Boggetto ND; Doucet CE; de Rosny EH; Vergely IB; Thierry NM; Amour AJ
J Pharm Belg; 1996; 51(3):161-4. PubMed ID: 8778349
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting viral proteases: challenges and opportunities.
Bianchi E; Pessi A
Biopolymers; 2002; 66(2):101-14. PubMed ID: 12325160
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and molecular characterization of a detergent-stable serine alkaline protease from Bacillus pumilus CBS with high catalytic efficiency.
Jaouadi B; Ellouz-Chaabouni S; Rhimi M; Bejar S
Biochimie; 2008 Sep; 90(9):1291-305. PubMed ID: 18397761
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.
Hoegl L; Korting HC; Klebe G
Pharmazie; 1999 May; 54(5):319-29. PubMed ID: 10368824
[TBL] [Abstract][Full Text] [Related]
11. [Cystatins, thyropins and inhibitors homologous to propeptides of cysteine proteases].
Gawlik K; Poreba W; Gutowicz J
Postepy Biochem; 2005; 51(3):318-27. PubMed ID: 16381176
[TBL] [Abstract][Full Text] [Related]
12. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
Abdel-Rahman HM; Kimura T; Hidaka K; Kiso A; Nezami A; Freire E; Hayashi Y; Kiso Y
Biol Chem; 2004 Nov; 385(11):1035-9. PubMed ID: 15576323
[TBL] [Abstract][Full Text] [Related]
13. Characterization of proteases from a stored product mite, Tyrophagus putrescentiae.
Ortego F; Sánchez-Ramos I; Ruiz M; Castañera P
Arch Insect Biochem Physiol; 2000 Mar; 43(3):116-24. PubMed ID: 10685099
[TBL] [Abstract][Full Text] [Related]
14. A genomic analysis of rat proteases and protease inhibitors.
Puente XS; López-Otín C
Genome Res; 2004 Apr; 14(4):609-22. PubMed ID: 15060002
[TBL] [Abstract][Full Text] [Related]
15. Conformational homogeneity in molecular recognition by proteolytic enzymes.
Tyndall JD; Fairlie DP
J Mol Recognit; 1999; 12(6):363-70. PubMed ID: 10611646
[TBL] [Abstract][Full Text] [Related]
16. Blocking of protease allergens with inhibitors reduces allergic responses in allergic rhinitis and other allergic diseases.
Suzuki M; Itoh M; Ohta N; Nakamura Y; Moriyama A; Matsumoto T; Ohashi T; Murakami S
Acta Otolaryngol; 2006 Jul; 126(7):746-51. PubMed ID: 16803715
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.
Baum EZ; Siegel MM; Bebernitz GA; Hulmes JD; Sridharan L; Sun L; Tabei K; Johnston SH; Wildey MJ; Nygaard J; Jones TR; Gluzman Y
Biochemistry; 1996 May; 35(18):5838-46. PubMed ID: 8639545
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
Supuran CT; Casini A; Scozzafava A
Med Res Rev; 2003 Sep; 23(5):535-58. PubMed ID: 12789686
[TBL] [Abstract][Full Text] [Related]
19. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
Wang SX; Pandey KC; Scharfstein J; Whisstock J; Huang RK; Jacobelli J; Fletterick RJ; Rosenthal PJ; Abrahamson M; Brinen LS; Rossi A; Sali A; McKerrow JH
Structure; 2007 May; 15(5):535-43. PubMed ID: 17502099
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.
Ganesh VK; Muller N; Judge K; Luan CH; Padmanabhan R; Murthy KH
Bioorg Med Chem; 2005 Jan; 13(1):257-64. PubMed ID: 15582469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
